Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial

Autor: Aggarwal, P., Aglawe, V., Ali, A., Anand, N., Awad, N., Bafna, V., Balasubramaniyam, G., Bandkar, A., Basha, P., Bharge, V., Bhate, A., Bhate, S., Bhavani, V., Bhosale, R., Chalapathy, DV, Chaubal, C., Chaudhary, D., Chavan, A., Desai, P., Dhodi, D., Dutta, S., Garg, R., Garg, K., George, M., Goyal, P., Guleria, R., Gupta, S., Jain, M., Jain, M.K., Jindal, S., Kalra, M., Kant, S., Khosla, P., Kulkarni, P., Kumar, P., Kumar, Y., Majumdar, A., Meshram, P., Mishra, V., Mohanty, S., Nair, J., Pandey, S., Panigrahi, S.K., Patil, B., Patil, V., Rahate, P., Raj, V., Ramanand, S., Rami, K., Ramraj, B., Rane, S., Rao, E.V., Rao, N., Raphael, R., Reddy, G., Redkar, V., Redkar, S., Sachdeva, A., Saha, J., Sahoo, J., Sampath, P., Savith, A., Shah, M., Shanmugam, L., Sharma, R., Sharma, P., Sharma, D., Singh, A., Singh, J., Singh, P., Sivaprakasam, S., Subramaniam, S., Sudheer, D., Tandon, S., Tariq, M., Tripathi, V., Vable, M., Verma, R., Waghmare, S., Ella, Raches, Reddy, Siddarth, Blackwelder, William, Potdar, Varsha, Yadav, Pragya, Sarangi, Vamshi, Aileni, Vinay K, Kanungo, Suman, Rai, Sanjay, Reddy, Prabhakar, Verma, Savita, Singh, Chandramani, Redkar, Sagar, Mohapatra, Satyajit, Pandey, Anil, Ranganadin, Pajanivel, Gumashta, Raghavendra, Multani, Manish, Mohammad, Shameem, Bhatt, Parul, Kumari, Laxmi, Sapkal, Gajanan, Gupta, Nivedita, Abraham, Priya, Panda, Samiran, Prasad, Sai, Bhargava, Balram, Ella, Krishna, Vadrevu, Krishna Mohan ^*

Publikováno v: In The Lancet 11-17 December 2021 398(10317):2173-2184

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial

Autor: Ella, Raches, Vadrevu, Krishna Mohan ^*, Jogdand, Harsh, Prasad, Sai, Reddy, Siddharth, Sarangi, Vamshi, Ganneru, Brunda, Sapkal, Gajanan, Yadav, Pragya, Abraham, Priya, Panda, Samiran, Gupta, Nivedita, Reddy, Prabhakar, Verma, Savita, Kumar Rai, Sanjay, Singh, Chandramani, Redkar, Sagar Vivek, Gillurkar, Chandra Sekhar, Kushwaha, Jitendra Singh, Mohapatra, Satyajit, Rao, Venkat, Guleria, Randeep, Ella, Krishna, Bhargava, Balram

Publikováno v: In The Lancet Infectious Diseases May 2021 21(5):637-646

Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin^®).

Autor: Singh, Chandramani, Verma, Savita, Reddy, Prabhakar, Diamond, Michael S., Curiel, David T., Patel, Chintan, Jain, Manish Kumar, Redkar, Sagar Vivek, Bhate, Amit Suresh, Gundappa, Vivek, Konatham, Rambabu, Toppo, Leelabati, Joshi, Aniket Chandrakant, Kushwaha, Jitendra Singh, Singh, Ajit Pratap, Bawankule, Shilpa, Ella, Raches, Prasad, Sai, Ganneru, Brunda, Chiteti, Siddharth Reddy

Publikováno v: NPJ Vaccines; 8/18/2023, Vol. 8 Issue 1, p1-9, 9p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.